(Q33770211)

29 July 2017

Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus (English)

1 reference

29 July 2017

Staphylococcus aureus

1 reference

Hiep N'Guyen Trong

1

1 reference

29 July 2017

Anne-Laure Prunier

series ordinal

2

1 reference

29 July 2017

Roland Leclercq

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

1 reference

29 July 2017

49

1 reference

29 July 2017

2098-2101

1 reference

29 July 2017

5

1 reference

Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

The role of mutators in the emergence of antibiotic-resistant bacteria

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Fluoroquinolone resistance among Gram-positive cocci

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Mutator bacteria as a risk factor in treatment of infectious diseases

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

High frequency of mutator strains among human uropathogenic Escherichia coli isolates.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Molecular mechanisms of DNA mismatch repair

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Trends in bacterial resistance to fluoroquinolones

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087674

Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15855537

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genetic analysis of Bacillus subtilis mutator genes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15855537

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.49.5.2098-2101.2005

1 reference

29 July 2017

1 reference

29 July 2017

1 reference